Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Melanoma: HELP
Richard F. Kefford
Based on 136 articles published since 2007
||||
Expertise Level
The expertise of Richard F. Kefford ranks in the
  • Top 0.024%
  • ... of 102,486 published authors worldwide on Melanoma
  • ... from 2007 through 2018
  • ... based on contributions to 136 articles on the topic.
Graphical view (beta)
Uncounted papers?
Get your prestigious
World Expert badge
similar to this:
 
Aliases Kefford, Richard   ·   Kefford, R F   ·   Kefford, Richard F   ·   Kefford, R
Work Locations
Details
Most likely:    Westmead Hospital      
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia. · Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27863085
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • Princess Alexandra Hospital, Greenslopes Private Hospital and University of Queensland, Brisbane, Queensland, Australia. · Melanoma Institute Australia, Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, New South Wales, Australia. · Peter MacCallum Cancer Centre and Cabrini Health, Melbourne, Victoria, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · School of Medicine and Pharmacology, University of Western Australia and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. · Queen Elizabeth Hospital, Adelaide, South Australia, Australia. · Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia. · The Alfred Hospital, Melbourne, Victoria, Australia. · Olivia Newton John Cancer Wellness & Research Centre, Austin Health Melbourne, Victoria, Australia. · Pubmed 27905182
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: · Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Research and Education Network, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 26793994
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • Department of Medicine, Arizona Cancer Center, Tucson, USA · Department of Medical Oncology, Fondazione IRCCS National Tumor Institute, Milan, Italy. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and School of Medicine, University of Adelaide, Adelaide. · Sydney West Cancer Trials Centre/Westmead Hospital and Melanoma Institute Australia, University of Sydney, North Sydney, Australia. · Department of Dermatology, University of Mainz, Mainz, Germany. · Melanoma and Muscle Cutaneous Sarcoma Division, European Institute of Oncology, Milan, Italy. · Department of Medicine, Seattle Cancer Care Alliance, Seattle, USA. · Department of Dermatology and Oncology, Hannover Medical School, Hannover, Germany. · Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, USA. · Department of Medical Oncology, Alfred Hospital, Melbourne, Australia. · Demartology Unit, Department of Medicine, The Gustave Roussy Cancer Institute, Villejuif, France. · Department of Medical Oncology, London Health Sciences Center-London Regional Cancer Program, London, Canada. · Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, USA. · Department of Dermatology, Timone Hospital, APHM and Aix-Marseille University, Marseille, France. · Department of Internal Medicine, Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Hematology and Oncology, St Luke's Cancer Center and Temple University, Bethlehem. · Biometrics and Data Operations/Translational Medicine/Biometrics and Data Operations/Clinical Research & Development/Global Medical Affairs, Celgene Corporation, Summit, USA. · Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 26410620
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
2014
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · GlaxoSmithKline Medicines Research Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia. · Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, California. · Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. · Cancer Council Trials and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia. · Division of Medical Oncology, New York University School of Medicine, New York, New York. · Prince of Wales Clinical School, University of New South Wales, Randwick, Australia. · GlaxoSmithKline Research and Development, Philadelphia, Pennsylvania and Research Triangle Park, North Carolina. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 24958809
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23246970
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2010
  • Westmead Institute for Cancer research and Melanoma Institute of Australia, University of Sydney at Westmead Hospital, NSW 2145, Australia. · Pubmed 20350333
2009
  • Department of Medicine, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 19367282
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton; Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA; Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD; Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland; Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL; Joanna M. Brell, MetroHealth Medical Center, Cleveland; William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Mark R. Albertini, University of Wisconsin Hospital, Madison, WI; Michael B. Atkins, Georgetown Medical Center, Washington, DC; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL; Jeffrey A. Sosman, Vanderbilt University, Nashville; Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN; Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI; Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada; and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia. · Pubmed 28135150
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • aCrown Princess Mary Cancer Centre bBlood and Marrow Transplant Service, Department of Haematology cDepartment of Clinical Immunology and Allergy, Westmead Hospital dFaculty of Medicine, The University of Sydney eMelanoma Institute Australia fFaculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26795275
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • Department of Dermatology, Westmead Hospital, Darcy Rd, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25040674
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Department of Diabetes and Endocrinology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia. · Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia. · Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. · Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26010858
  • *The Crown Princess Mary Cancer Centre ∥Rheumatology Department, Westmead Hospital †Melanoma Institute Australia ‡Sydney Medical School, The University of Sydney §Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, NSW, Australia. · Pubmed 25415286
  • Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 25159853
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Departments of aDermatology bMedical Oncology, Westmead Hospital cSydney Medical School, The University of Sydney dMelanoma Institute Australia, Sydney, New South Wales, Australia eDepartment of Dermatology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Pubmed 24922191
  • Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 24496868
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24313958
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • Westmead Millennium Institute, The University of Sydney, Sydney, Australia. · Pubmed 22981500
  • Department of Dermatology(D5a), Westmead Hospital, Westmead, Sydney, NSW, 2145, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23870055
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 23582185
  • Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 23509307
  • Department of Nuclear Medicine, PET and Ultrasound, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 23425235
  • Melanoma Institute Australia and Westmead Hospital, University of Sydney, 40 Rocklands Road, North Sydney, New South Wales, Australia. · Pubmed 23237741
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 22931913
2012
  • Melanoma Institute Australia, Westmead Institute for Cancer Research, and Westmead Hospital, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23051966
  • Department of Dermatology, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 22804352
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
2010
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 20478260
  • Westmead Institute for Cancer Research and Melanoma Institute of Australia, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 20340136
2009
  • Westmead Institute for Cancer Research, Westmead Hospital, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 19212341
  • Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute and Westmead Hospital, Australia. · Pubmed 19149898
2008
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 18953432
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 18843795
Probable:    Mater Hospital      
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. · Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The University of Sydney at the Westmead Institute for Medical Research, Centre for Cancer Research, Westmead New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia. · Royal North Shore Hospital, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. · Pubmed 28724663
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia. · Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27863085
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Royal North Shore Hospital, Sydney, NSW, Australia. · Mater Hospital, Sydney, NSW, Australia. · Department of Nuclear Medicine, Westmead Hospital, Sydney, NSW, Australia. · Faculty of Health and Medical Sciences, Macquarie University, Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27333363
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: · Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Research and Education Network, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 26793994
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • Department of Medicine, Arizona Cancer Center, Tucson, USA · Department of Medical Oncology, Fondazione IRCCS National Tumor Institute, Milan, Italy. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and School of Medicine, University of Adelaide, Adelaide. · Sydney West Cancer Trials Centre/Westmead Hospital and Melanoma Institute Australia, University of Sydney, North Sydney, Australia. · Department of Dermatology, University of Mainz, Mainz, Germany. · Melanoma and Muscle Cutaneous Sarcoma Division, European Institute of Oncology, Milan, Italy. · Department of Medicine, Seattle Cancer Care Alliance, Seattle, USA. · Department of Dermatology and Oncology, Hannover Medical School, Hannover, Germany. · Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, USA. · Department of Medical Oncology, Alfred Hospital, Melbourne, Australia. · Demartology Unit, Department of Medicine, The Gustave Roussy Cancer Institute, Villejuif, France. · Department of Medical Oncology, London Health Sciences Center-London Regional Cancer Program, London, Canada. · Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, USA. · Department of Dermatology, Timone Hospital, APHM and Aix-Marseille University, Marseille, France. · Department of Internal Medicine, Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Hematology and Oncology, St Luke's Cancer Center and Temple University, Bethlehem. · Biometrics and Data Operations/Translational Medicine/Biometrics and Data Operations/Clinical Research & Development/Global Medical Affairs, Celgene Corporation, Summit, USA. · Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 26410620
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
2014
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · GlaxoSmithKline Medicines Research Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia. · Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, California. · Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. · Cancer Council Trials and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia. · Division of Medical Oncology, New York University School of Medicine, New York, New York. · Prince of Wales Clinical School, University of New South Wales, Randwick, Australia. · GlaxoSmithKline Research and Development, Philadelphia, Pennsylvania and Research Triangle Park, North Carolina. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 24958809
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23246970
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25477049
  • *The Crown Princess Mary Cancer Centre ∥Rheumatology Department, Westmead Hospital †Melanoma Institute Australia ‡Sydney Medical School, The University of Sydney §Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, NSW, Australia. · Pubmed 25415286
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • Melanoma Institute Australia, Sydney, New South Wales 2060, Australia; · Pubmed 24489105
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 24496868
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23403819
  • Melanoma Institute Australia and Westmead Hospital, University of Sydney, 40 Rocklands Road, North Sydney, New South Wales, Australia. · Pubmed 23237741
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
2012
  • Melanoma Institute Australia, Westmead Institute for Cancer Research, and Westmead Hospital, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23051966
  • Melanoma Institute Australia, Australia. · Pubmed 22962325
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22156613
2011
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
2009
  • Melanoma Institute Australia, North Sydney, NSW 2060, Australia. · Pubmed 19647595
Probable:    University of Sydney      
2017
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
2016
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • Department of Medicine, Arizona Cancer Center, Tucson, USA · Department of Medical Oncology, Fondazione IRCCS National Tumor Institute, Milan, Italy. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and School of Medicine, University of Adelaide, Adelaide. · Sydney West Cancer Trials Centre/Westmead Hospital and Melanoma Institute Australia, University of Sydney, North Sydney, Australia. · Department of Dermatology, University of Mainz, Mainz, Germany. · Melanoma and Muscle Cutaneous Sarcoma Division, European Institute of Oncology, Milan, Italy. · Department of Medicine, Seattle Cancer Care Alliance, Seattle, USA. · Department of Dermatology and Oncology, Hannover Medical School, Hannover, Germany. · Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, USA. · Department of Medical Oncology, Alfred Hospital, Melbourne, Australia. · Demartology Unit, Department of Medicine, The Gustave Roussy Cancer Institute, Villejuif, France. · Department of Medical Oncology, London Health Sciences Center-London Regional Cancer Program, London, Canada. · Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, USA. · Department of Dermatology, Timone Hospital, APHM and Aix-Marseille University, Marseille, France. · Department of Internal Medicine, Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Hematology and Oncology, St Luke's Cancer Center and Temple University, Bethlehem. · Biometrics and Data Operations/Translational Medicine/Biometrics and Data Operations/Clinical Research & Development/Global Medical Affairs, Celgene Corporation, Summit, USA. · Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 26410620
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
2014
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · GlaxoSmithKline Medicines Research Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia. · Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, California. · Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. · Cancer Council Trials and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia. · Division of Medical Oncology, New York University School of Medicine, New York, New York. · Prince of Wales Clinical School, University of New South Wales, Randwick, Australia. · GlaxoSmithKline Research and Development, Philadelphia, Pennsylvania and Research Triangle Park, North Carolina. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 24958809
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23246970
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2010
  • Westmead Institute for Cancer research and Melanoma Institute of Australia, University of Sydney at Westmead Hospital, NSW 2145, Australia. · Pubmed 20350333
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • aCrown Princess Mary Cancer Centre bBlood and Marrow Transplant Service, Department of Haematology cDepartment of Clinical Immunology and Allergy, Westmead Hospital dFaculty of Medicine, The University of Sydney eMelanoma Institute Australia fFaculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26795275
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • Department of Dermatology, Westmead Hospital, Darcy Rd, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25040674
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Department of Diabetes and Endocrinology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia. · Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia. · Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. · Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26010858
  • Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25477049
  • *The Crown Princess Mary Cancer Centre ∥Rheumatology Department, Westmead Hospital †Melanoma Institute Australia ‡Sydney Medical School, The University of Sydney §Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, NSW, Australia. · Pubmed 25415286
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • aWestmead Hospital bWestmead Institute for Cancer Research, Westmead cMelanoma Institute Australia dSydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25054915
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Departments of aDermatology bMedical Oncology, Westmead Hospital cSydney Medical School, The University of Sydney dMelanoma Institute Australia, Sydney, New South Wales, Australia eDepartment of Dermatology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Pubmed 24922191
  • 1The University of Sydney, Sydney 2Melanoma Institute Australia, North Sydney 3Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 4Canterbury Health Laboratories, Christchurch, New Zealand 5Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst 6Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 24614711
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24313958
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • Westmead Millennium Institute, The University of Sydney, Sydney, Australia. · Pubmed 22981500
  • Department of Dermatology(D5a), Westmead Hospital, Westmead, Sydney, NSW, 2145, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23870055
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 23582185
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia and Westmead Hospital, University of Sydney, 40 Rocklands Road, North Sydney, New South Wales, Australia. · Pubmed 23237741
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 22931913
2012
  • Melanoma Institute Australia, Westmead Institute for Cancer Research, and Westmead Hospital, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23051966
  • Department of Dermatology, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 22804352
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
  • Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Pubmed 22095472
2011
  • Centre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology, Melbourne School of Population Health, University of Melbourne, VIC, Australia. · Pubmed 21472378
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
  • Center for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia. · Pubmed 21325014
2010
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 20478260
  • Westmead Institute for Cancer Research and Melanoma Institute of Australia, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 20340136
2009
  • Westmead Institute for Cancer Research, Westmead Hospital, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 19212341
  • Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute and Westmead Hospital, Australia. · Pubmed 19149898
2008
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 18953432
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 18843795
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 136 total) written by Richard F. Kefford about Melanoma:

  • Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma. 2017
  • Standard-dose pembrolizumab in combination with reduced-dose ipilimumab for patients with advanced melanoma (KEYNOTE-029): an open-label, phase 1b trial. 2017
  • Phase I Dose-Escalation and -Expansion Study of the BRAF Inhibitor Encorafenib (LGX818) in Metastatic 2017
  • Phase III Randomized Study of 4 Weeks of High-Dose Interferon-α-2b in Stage T2bNO, T3a-bNO, T4a-bNO, and T1-4N1a-2a (microscopic) Melanoma: A Trial of the Eastern Cooperative Oncology Group-American College of Radiology Imaging Network Cancer Research Group (E1697). 2017
  • Vemurafenib in metastatic melanoma patients with brain metastases: an open-label, single-arm, phase 2, multicentre study. 2017
  • PD-L1 Expression and Immune Escape in Melanoma Resistance to MAPK Inhibitors. 2017
  • Efficacy of anti-PD-1 therapy in patients with melanoma brain metastases. 2017
  • Whole-genome landscapes of major melanoma subtypes. 2017
  • Circulating tumour DNA predicts response to anti-PD1 antibodies in metastatic melanoma. 2017
  • Pharmacokinetics of dabrafenib in a patient with metastatic melanoma undergoing haemodialysis. 2017
Show List of Full Article Records
Google Searches

Learn more about Richard F. Kefford using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Westmead Hospital
Mater Hospital
University of Sydney
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Westmead Hospital
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia. · Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27863085
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • Princess Alexandra Hospital, Greenslopes Private Hospital and University of Queensland, Brisbane, Queensland, Australia. · Melanoma Institute Australia, Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, New South Wales, Australia. · Peter MacCallum Cancer Centre and Cabrini Health, Melbourne, Victoria, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · School of Medicine and Pharmacology, University of Western Australia and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. · Queen Elizabeth Hospital, Adelaide, South Australia, Australia. · Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia. · The Alfred Hospital, Melbourne, Victoria, Australia. · Olivia Newton John Cancer Wellness & Research Centre, Austin Health Melbourne, Victoria, Australia. · Pubmed 27905182
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: · Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Research and Education Network, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 26793994
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • Department of Medicine, Arizona Cancer Center, Tucson, USA · Department of Medical Oncology, Fondazione IRCCS National Tumor Institute, Milan, Italy. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and School of Medicine, University of Adelaide, Adelaide. · Sydney West Cancer Trials Centre/Westmead Hospital and Melanoma Institute Australia, University of Sydney, North Sydney, Australia. · Department of Dermatology, University of Mainz, Mainz, Germany. · Melanoma and Muscle Cutaneous Sarcoma Division, European Institute of Oncology, Milan, Italy. · Department of Medicine, Seattle Cancer Care Alliance, Seattle, USA. · Department of Dermatology and Oncology, Hannover Medical School, Hannover, Germany. · Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, USA. · Department of Medical Oncology, Alfred Hospital, Melbourne, Australia. · Demartology Unit, Department of Medicine, The Gustave Roussy Cancer Institute, Villejuif, France. · Department of Medical Oncology, London Health Sciences Center-London Regional Cancer Program, London, Canada. · Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, USA. · Department of Dermatology, Timone Hospital, APHM and Aix-Marseille University, Marseille, France. · Department of Internal Medicine, Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Hematology and Oncology, St Luke's Cancer Center and Temple University, Bethlehem. · Biometrics and Data Operations/Translational Medicine/Biometrics and Data Operations/Clinical Research & Development/Global Medical Affairs, Celgene Corporation, Summit, USA. · Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 26410620
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
2014
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · GlaxoSmithKline Medicines Research Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia. · Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, California. · Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. · Cancer Council Trials and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia. · Division of Medical Oncology, New York University School of Medicine, New York, New York. · Prince of Wales Clinical School, University of New South Wales, Randwick, Australia. · GlaxoSmithKline Research and Development, Philadelphia, Pennsylvania and Research Triangle Park, North Carolina. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 24958809
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23246970
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2010
  • Westmead Institute for Cancer research and Melanoma Institute of Australia, University of Sydney at Westmead Hospital, NSW 2145, Australia. · Pubmed 20350333
2009
  • Department of Medicine, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 19367282
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Sanjiv S. Agarwala, Saint Luke's University Hospital, Easton; Uma N. Rao, Ahmad A. Tarhini, Terry L. Evans, and John M. Kirkwood, University of Pittsburgh Medical Center, Pittsburgh, PA; Sandra J. Lee, and Waiki Yip, Dana Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, MA; Gary I. Cohen, Greater Baltimore Medical Center, Baltimore, MD; Douglas S. Reintgen, Lakeland Regional Cancer Center, Lakeland; Vernon K. Sondak, H. Lee Moffitt Cancer Center, Tampa, FL; Joanna M. Brell, MetroHealth Medical Center, Cleveland; William E. Carson, The Ohio State University Comprehensive Cancer Center, Columbus, OH; Mark R. Albertini, University of Wisconsin Hospital, Madison, WI; Michael B. Atkins, Georgetown Medical Center, Washington, DC; Shaker R. Dakhil, Cancer Center of Kansas, Wichita, KS; Robert M. Conry, University of Alabama at Birmingham, Birmingham, AL; Jeffrey A. Sosman, Vanderbilt University, Nashville; Alberto S. Pappo, Saint Jude Children's Research Hospital Oncology, Memphis, TN; Lawrence E. Flaherty, Wayne State University/Karmanos Cancer Institute, Detroit, MI; Michael G. Smylie, Cross Cancer Institute, Edmonton, Canada; and Richard F. Kefford, Sydney West Area Health Service, Westmead, Australia. · Pubmed 28135150
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • aCrown Princess Mary Cancer Centre bBlood and Marrow Transplant Service, Department of Haematology cDepartment of Clinical Immunology and Allergy, Westmead Hospital dFaculty of Medicine, The University of Sydney eMelanoma Institute Australia fFaculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26795275
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • Department of Dermatology, Westmead Hospital, Darcy Rd, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25040674
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Department of Diabetes and Endocrinology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia. · Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia. · Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. · Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26010858
  • *The Crown Princess Mary Cancer Centre ∥Rheumatology Department, Westmead Hospital †Melanoma Institute Australia ‡Sydney Medical School, The University of Sydney §Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, NSW, Australia. · Pubmed 25415286
  • Department of Dermatology, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 25159853
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Departments of aDermatology bMedical Oncology, Westmead Hospital cSydney Medical School, The University of Sydney dMelanoma Institute Australia, Sydney, New South Wales, Australia eDepartment of Dermatology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Pubmed 24922191
  • Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 24496868
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24313958
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • Westmead Millennium Institute, The University of Sydney, Sydney, Australia. · Pubmed 22981500
  • Department of Dermatology(D5a), Westmead Hospital, Westmead, Sydney, NSW, 2145, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23870055
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 23582185
  • Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 23509307
  • Department of Nuclear Medicine, PET and Ultrasound, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 23425235
  • Melanoma Institute Australia and Westmead Hospital, University of Sydney, 40 Rocklands Road, North Sydney, New South Wales, Australia. · Pubmed 23237741
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 22931913
2012
  • Melanoma Institute Australia, Westmead Institute for Cancer Research, and Westmead Hospital, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23051966
  • Department of Dermatology, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 22804352
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
2010
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 20478260
  • Westmead Institute for Cancer Research and Melanoma Institute of Australia, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 20340136
2009
  • Westmead Institute for Cancer Research, Westmead Hospital, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 19212341
  • Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute and Westmead Hospital, Australia. · Pubmed 19149898
2008
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 18953432
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 18843795
Mater Hospital
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. · Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The University of Sydney at the Westmead Institute for Medical Research, Centre for Cancer Research, Westmead New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia. · Royal North Shore Hospital, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. · Pubmed 28724663
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia. · Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27863085
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Royal North Shore Hospital, Sydney, NSW, Australia. · Mater Hospital, Sydney, NSW, Australia. · Department of Nuclear Medicine, Westmead Hospital, Sydney, NSW, Australia. · Faculty of Health and Medical Sciences, Macquarie University, Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27333363
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
  • Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. Electronic address: · Department of Dermatology, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Research and Education Network, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia. · Tissue Pathology and Diagnostic Oncology, Westmead Hospital, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Sydney Medical School, University of Sydney, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 26793994
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • Department of Medicine, Arizona Cancer Center, Tucson, USA · Department of Medical Oncology, Fondazione IRCCS National Tumor Institute, Milan, Italy. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and School of Medicine, University of Adelaide, Adelaide. · Sydney West Cancer Trials Centre/Westmead Hospital and Melanoma Institute Australia, University of Sydney, North Sydney, Australia. · Department of Dermatology, University of Mainz, Mainz, Germany. · Melanoma and Muscle Cutaneous Sarcoma Division, European Institute of Oncology, Milan, Italy. · Department of Medicine, Seattle Cancer Care Alliance, Seattle, USA. · Department of Dermatology and Oncology, Hannover Medical School, Hannover, Germany. · Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, USA. · Department of Medical Oncology, Alfred Hospital, Melbourne, Australia. · Demartology Unit, Department of Medicine, The Gustave Roussy Cancer Institute, Villejuif, France. · Department of Medical Oncology, London Health Sciences Center-London Regional Cancer Program, London, Canada. · Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, USA. · Department of Dermatology, Timone Hospital, APHM and Aix-Marseille University, Marseille, France. · Department of Internal Medicine, Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Hematology and Oncology, St Luke's Cancer Center and Temple University, Bethlehem. · Biometrics and Data Operations/Translational Medicine/Biometrics and Data Operations/Clinical Research & Development/Global Medical Affairs, Celgene Corporation, Summit, USA. · Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 26410620
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
2014
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · GlaxoSmithKline Medicines Research Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia. · Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, California. · Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. · Cancer Council Trials and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia. · Division of Medical Oncology, New York University School of Medicine, New York, New York. · Prince of Wales Clinical School, University of New South Wales, Randwick, Australia. · GlaxoSmithKline Research and Development, Philadelphia, Pennsylvania and Research Triangle Park, North Carolina. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 24958809
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23246970
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25477049
  • *The Crown Princess Mary Cancer Centre ∥Rheumatology Department, Westmead Hospital †Melanoma Institute Australia ‡Sydney Medical School, The University of Sydney §Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, NSW, Australia. · Pubmed 25415286
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • Melanoma Institute Australia, Sydney, New South Wales 2060, Australia; · Pubmed 24489105
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Westmead Hospital, Westmead, Australia; Melanoma Institute Australia, Sydney, Australia. · Pubmed 24496868
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23403819
  • Melanoma Institute Australia and Westmead Hospital, University of Sydney, 40 Rocklands Road, North Sydney, New South Wales, Australia. · Pubmed 23237741
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
2012
  • Melanoma Institute Australia, Westmead Institute for Cancer Research, and Westmead Hospital, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23051966
  • Melanoma Institute Australia, Australia. · Pubmed 22962325
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 22736239
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 22156613
2011
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
2009
  • Melanoma Institute Australia, North Sydney, NSW 2060, Australia. · Pubmed 19647595
University of Sydney
2017
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
2016
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia. · Cancer Therapy Centre, Liverpool Hospital, Liverpool; The University of New South Wales, Kensington, New South Wales, Australia. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · The University of Sydney; Melanoma Institute Australia; Royal North Shore Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney; The University of Newcastle, Newcastle, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital; Westmead Institute for Cancer Research, Westmead; The University of Sydney; Melanoma Institute Australia, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; The University of Sydney, Sydney, New South Wales, Australia · Pubmed 24868021
2015
  • Department of Medicine, Arizona Cancer Center, Tucson, USA · Department of Medical Oncology, Fondazione IRCCS National Tumor Institute, Milan, Italy. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and School of Medicine, University of Adelaide, Adelaide. · Sydney West Cancer Trials Centre/Westmead Hospital and Melanoma Institute Australia, University of Sydney, North Sydney, Australia. · Department of Dermatology, University of Mainz, Mainz, Germany. · Melanoma and Muscle Cutaneous Sarcoma Division, European Institute of Oncology, Milan, Italy. · Department of Medicine, Seattle Cancer Care Alliance, Seattle, USA. · Department of Dermatology and Oncology, Hannover Medical School, Hannover, Germany. · Division of Hematology and Oncology, University of Alabama at Birmingham, Birmingham, USA. · Department of Medical Oncology, Alfred Hospital, Melbourne, Australia. · Demartology Unit, Department of Medicine, The Gustave Roussy Cancer Institute, Villejuif, France. · Department of Medical Oncology, London Health Sciences Center-London Regional Cancer Program, London, Canada. · Department of Medical Oncology, Banner MD Anderson Cancer Center, Gilbert, USA. · Department of Dermatology, Timone Hospital, APHM and Aix-Marseille University, Marseille, France. · Department of Internal Medicine, Division of Medical Oncology, Ohio State University Comprehensive Cancer Center, Columbus. · Department of Hematology and Oncology, St Luke's Cancer Center and Temple University, Bethlehem. · Biometrics and Data Operations/Translational Medicine/Biometrics and Data Operations/Clinical Research & Development/Global Medical Affairs, Celgene Corporation, Summit, USA. · Department of Dermatology, University Medical Center Schleswig-Holstein, Kiel, Germany. · Pubmed 26410620
  • Melanoma Institute Australia and The University of Sydney, Sydney, Australia · University of California San Francisco, San Francisco. · Clinical Statistics, GlaxoSmithKline, Collegeville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Hospital, University of Sydney, Sydney Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Massachusetts General Hospital Center, Boston. · Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa. · Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville. · California Pacific Medical Center, San Francisco. · Department of Medical Oncology, The University of Colorado Cancer Center, Aurora. · Department of Oncology, The Angeles Clinic and Research Institute, Santa Monica. · Penn Medicine, The University of Pennsylvania, Philadelphia, USA. · Oncology Unit, Ludwig Institute for Cancer Research, Heidelberg, Australia. · Department of Oncology, Vanderbilt University Medical Centre, Nashville, USA. · Melanoma Institute Australia and The University of Sydney, Sydney, Australia Westmead Millennium Institute, University of Sydney, Sydney, Australia. · Pubmed 25411413
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
  • Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital, Sydney, Australia. · Westmead Hospital, Sydney, Australia. · Queensland Centre for Medical Genomics; Institute of Molecular Bioscience, University of Queensland, St Lucia, Brisbane, Australia. · Canberra Hospital and Australian National University Medical School, Canberra, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital, Sydney, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead; Millennium Institute; Westmead Hospital; Melanoma Institute Australia, Sydney, Australia. · The Kinghorn Cancer Centre, Garvan Institute of Medical Research, Sydney; South Western Sydney Clinical School, University of New South Wales, Liverpool, Australia; Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow; Glasgow Royal Infirmary, Glasgow, Scotland, United Kingdom. · Melanoma Institute Australia; The University of Sydney and Westmead Institute for Cancer Research, Sydney, Australia · Pubmed 24821886
2014
  • Gustave Roussy and INSERM U981, Paris-Sud, France. Electronic address: · University of California Los Angeles, Los Angeles, CA, USA. · Memorial Sloan-Kettering Cancer Center, New York, NY, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Angeles Clinic and Research Institute, Los Angeles, CA, USA. · Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Westmead, NSW, Australia; University of Sydney, Sydney, NSW, Australia. · H Lee Moffitt Cancer Center, Tampa, FL, USA. · Princess Margaret Cancer Centre, Toronto, ON, Canada. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA. · South Texas Accelerated Research Therapeutics, San Antonio, TX, USA. · Mayo Clinic, Rochester, MN, USA. · University of Pittsburgh, Pittsburgh, PA, USA. · Mayo Clinic, Jacksonville, FL, USA. · Gustave Roussy and INSERM U981, Paris-Sud, France. · Merck, Whitehouse Station, NJ, USA. · University of California San Francisco, San Francisco, CA, USA. · Pubmed 25034862
  • Division of Cancer Medicine, Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Moores Cancer Center, University of California San Diego, La Jolla, California. · Division of Cancer Medicine, Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas. · GlaxoSmithKline Medicines Research Unit, Prince of Wales Hospital, Randwick, New South Wales, Australia. · Cancer Clinical Trials Unit, Royal Adelaide Hospital and University of Adelaide, Adelaide, South Australia, Australia. · Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, California. · Drug Development Unit, Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Nashville, Tennessee. · Cancer Council Trials and Sir Charles Gairdner Hospital and University of Western Australia, Perth, Western Australia, Australia. · Division of Medical Oncology, New York University School of Medicine, New York, New York. · Prince of Wales Clinical School, University of New South Wales, Randwick, Australia. · GlaxoSmithKline Research and Development, Philadelphia, Pennsylvania and Research Triangle Park, North Carolina. · Melanoma Institute Australia and University of Sydney, New South Wales, Australia. Westmead Institute for Cancer Research, Westmead Millennium Institute, and Department of Medical Oncology, Westmead Hospital, Sydney, New South Wales, Australia. · Pubmed 24958809
  • Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China. · Department of Community and Family Medicine, Center for Genomic Medicine, Geisel School of Medicine, Dartmouth College, Lebanon, NH 03755, USA. · Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX 77030, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA. · Queensland Institute of Medical Research, Brisbane, Queensland 4029, Australia. · Leeds Institute of Cancer and Pathology, University of Leeds, Leeds LS9 7TF, UK. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia, Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Centre for Molecular, Environmental, Genetic and Analytic Epidemiology, School of Population Health, University of Melbourne, Melbourne, Victoria 3052, Australia. · Westmead Institute of Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead, New South Wales 2145, Australia. · Cancer Epidemiology Centre, The Cancer Council Victoria, Carlton, Victoria 3053, Australia. · Cancer Epidemiology and Services Research, Sydney School of Public Health, University of Sydney, Sydney, New South Wales 2006, Australia. · Viertel Centre for Research in Cancer Control, Cancer Council Queensland, Brisbane, Queensland 4004, Australia. · Laboratory of Translational Genomics, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD 20852, USA. · Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA. · Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4029, Australia. · Duke Cancer Institute, Duke University Medical Center, Durham, NC 27710, USA, · Department of Epidemiology and Biostatistics, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center of Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin 300060, P.R. China, Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA, Channing Division of Network Medicine and Department of Dermatology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA, Department of Epidemiology, Fairbanks School of Public Health, Indiana University, Indianapolis, IN 46202, USA, Simon Cancer Center, Indiana University, Indianapolis, IN 46202, USA and Department of Dermatology, School of Medicine, Indiana University, Indianapolis, IN 46202, USA · Pubmed 24980573
  • 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia [4] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Department of Medical Genomics, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] School of Medicine, University of Western Sydney, Sydney, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · 1] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [2] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia [3] The Kinghorn Cancer Centre and Cancer Program Garvan Institute of Medical Research, Victoria Street, Darlinghurst, New South Wales, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales, Australia [2] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia [3] Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24918823
  • Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America; The Group Health Research Institute, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia. · Division of Dermatology, University of Washington Department of Medicine, Seattle, Washington, United States of America. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Westmead Institute for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia; The University of Sydney, Sydney, New South Wales, Australia; Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The Howard Hughes Medical Institute, Chevy Chase, Maryland, United States of America. · Pubmed 24733413
  • Center for Melanoma, Massachusetts General Hospital Cancer Center, Boston, MA, USA. · Biostatistics and Epidemiology, GlaxoSmithKline, Munich, Germany. · Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA, USA. · Unit of Melanoma, Cancer Immunotherapy and Innovative Therapy-Istituto Nazionale Tumori Fondazione "G Pascale", Napoli, Italy. · Department of Dermatology, University Hospital Zurich, Zurich, Switzerland. · Gustave Roussy Cancer Campus, Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, University Hospital Kiel, Kiel, Germany. · Westmead Hospital and Melanoma Institute Australia, University of Sydney, NSW, Australia. · Skin Cancer Program University of Pittsburgh Cancer Institute, Pittsburgh, PA, USA. · Melanoma Institute Australia and the University of Sydney, Sydney, NSW, Australia. · Institute of Cancer Sciences, Faculty of Medical & Human Sciences, University of Manchester, Manchester, UK. · Department of Internal Medicine 5-Hematology/Oncology, University of Erlangen, Erlangen, Germany. · Peter MacCallum Cancer Institute, St Andrews Place, East Melbourne, VIC, Australia. · Beverly Hills Cancer Center, Beverly Hills, CA, USA. · Academic Unit of Oncology, University of Nottingham, Nottingham, UK. · Dermatology and INSERM Unit 981 Gustave Roussy Cancer Campus and Paris-Sud University Grand Paris, Villejuif, France. · Department of Dermatology, University Hospital Essen, Essen, Germany. Electronic address: · Pubmed 24485879
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Kolling Institute of Medical Research, University of Sydney, St. Leonards, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. Electronic address: · Pubmed 24476679
  • 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA. · 1] Harvard Medical School, Boston, MA, USA [2] Department of Dermatology, Brigham and Women's Hospital, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Westmead Institute for Cancer Research, NSW, Sydney, Australia. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Mater Hospital, Sydney, NSW, Australia [4] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · 1] Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA [2] Harvard Medical School, Boston, MA, USA [3] Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA [4] Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA. · 1] Melanoma Institute Australia, Sydney, NSW, Australia [2] The University of Sydney, Camperdown, NSW, Australia [3] Royal Prince Alfred Hospital, Sydney, NSW, Australia. · Pubmed 24434899
  • Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia. · Melanoma Institute Australia, Sydney, Australia ; The University of Sydney, Sydney, Australia ; Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia ; Westmead Institute for Cancer Research, Westmead, Australia. · Westmead Hospital, Crown Princess Mary Cancer Centre, Sydney, Australia. · The University of Sydney, Sydney, Australia ; Westmead Hospital, Department of Radiology, Sydney, Australia. · Pubmed 24400126
  • Division of Dermatology, Department of Medicine. · David Geffen School of Medicine, University of California, LA, California 90095-1662 USA. · Department of Molecular and Medical Pharmacology. · Division of Surgical Oncology, Department of Surgery. · Division of Hematology & Oncology, Department of Medicine. · Department of Medicine. · Vanderbilt-Ingram Cancer Center, Nashville, TN 37232. · Department of Cancer Biology. · Department of Surgery. · Melanoma Institute of Australia, Westmead Millenium Institute, Westmead Hospital, University of Sydney, New South Wales, Australia. · Jonsson Comprehensive Cancer Center. · Ludwig Institute for Cancer Research, Brussels Branch, Belgium. · Pubmed 24265155
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Sydney, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Immunology and Oncology Unit, University of Newcastle, Newcastle, New South Wales, Australia. · Pubmed 23455323
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · 1] Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia [2] Melanoma Institute Australia, Sydney, New South Wales, Australia. · Pubmed 23246970
  • University Hospital, University Duisburg-Essen, Germany · Melanoma Institute Australia; and The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; and Sydney Medical School, The University of Sydney, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney; and Royal Prince Alfred Hospital, Sydney, Australia. · Melanoma Institute Australia; Sydney Medical School, The University of Sydney, Sydney; and Westmead Institute for Cancer Research, Westmead Hospital, Westmead, Australia. · Melanoma Institute Australia; Royal Prince Alfred Hospital; The University of Sydney; and Mater Hospital, Sydney, Australia. · University Hospital, University Duisburg-Essen, Germany. · Pubmed 25185100
2010
  • Westmead Institute for Cancer research and Melanoma Institute of Australia, University of Sydney at Westmead Hospital, NSW 2145, Australia. · Pubmed 20350333
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • aCrown Princess Mary Cancer Centre bBlood and Marrow Transplant Service, Department of Haematology cDepartment of Clinical Immunology and Allergy, Westmead Hospital dFaculty of Medicine, The University of Sydney eMelanoma Institute Australia fFaculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26795275
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • 1Service of Oncology, Hospital La Paz, Madrid, Spain; 2Department of Dermatology, Hopital Ste Marguerite, Marseille, France; 3Department of Dermatology, University Hospital of Zurich, Zurich, Switzerland; 4Department of Sarcoma and Melanoma, M. Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland; 5Department of Dermatology (CR), and General Director (AE), Institute Gustave Roussy, Villejuif Cedex, France; 6First Department of Medicine, University of Athens Medical School, Athens, Greece; 7Department of Oncology, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia; 8Service of Oncology, Clinica Universitaria de Navarra, Pamplona, Spain; 9Department of Dermatology, University of Kiel, Kiel, Germany; and 10Department of Dermatology, University Hospital Essen, Essen, Germany. · Pubmed 24413374
  • Department of Dermatology, Westmead Hospital, Darcy Rd, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25040674
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Department of Diabetes and Endocrinology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia. · Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia. · Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. · Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26010858
  • Melanoma Institute Australia, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 25477049
  • *The Crown Princess Mary Cancer Centre ∥Rheumatology Department, Westmead Hospital †Melanoma Institute Australia ‡Sydney Medical School, The University of Sydney §Westmead Institute for Cancer Research, Westmead Millennium Institute, Sydney, NSW, Australia. · Pubmed 25415286
2014
  • Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Douglas B. Johnson and Jeffrey A. Sosman, Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute and Tennessee Oncology, Nashville, TN; Keith T. Flaherty and Donald P. Lawrence, Massachusetts General Hospital Cancer Center, Boston MA; Jeffrey S. Weber and Geoffrey T. Gibney, Moffitt Cancer Center, Tampa, FL; Kevin B. Kim and Gerald S. Falchook, University of Texas MD Anderson Cancer Center, Houston, TX; Richard F. Kefford and Georgina V. Long, Melanoma Institute Australia, University of Sydney and Westmead Hospital, Sydney, New South Wales; Jonathan Cebon, Joint Ludwig-Austin Oncology Unit, Austin Health, Melbourne, Victoria, Australia; Omid Hamid, Angeles Clinic and Research Institute, Los Angeles; Alain Algazi and Adil Daud, University of California, San Francisco, San Francisco, CA; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Peng Sun, Shonda Little, and Elizabeth Cunningham, GlaxoSmithKline, Philadelphia, PA; William H. Sharfman, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD; Robert R. McWilliams, Mayo Clinic, Rochester, MN; Mario Sznol, Yale University School of Medicine and Smilow Cancer Center, Yale-New Haven Hospital, New Haven, CT; Karl Lewis and Rene Gonzalez, University of Colorado, Denver, CO; and Kiran Patel, Incyte, Wilmington, DE. · Pubmed 25287827
  • aWestmead Hospital bWestmead Institute for Cancer Research, Westmead cMelanoma Institute Australia dSydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25054915
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
  • Melanoma Institute Australia, Sydney, New South Wales, Australia; Department of Medical Oncology, Crown Princess Mary Cancer Center, Westmead Hospital, Sydney, New South Wales, Australia; University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24985732
  • Departments of aDermatology bMedical Oncology, Westmead Hospital cSydney Medical School, The University of Sydney dMelanoma Institute Australia, Sydney, New South Wales, Australia eDepartment of Dermatology, School of Medicine, Pontificia Universidad Catolica de Chile, Santiago, Chile. · Pubmed 24922191
  • 1The University of Sydney, Sydney 2Melanoma Institute Australia, North Sydney 3Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 4Canterbury Health Laboratories, Christchurch, New Zealand 5Kinghorn Cancer Centre, Garvan Institute of Medical Research, Darlinghurst 6Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Pubmed 24614711
  • Authors' Affiliations: Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute; Departments of Medical Oncology and Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead; Melanoma Institute Australia; Disciplines of Pathology, Medicine, and Surgery, Sydney Medical School, The University of Sydney, Sydney; Departments of Melanoma and Surgical Oncology and Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Pubmed 24463458
  • *Melanoma Institute Australia Discipline of †Medicine §Pathology #Surgery, The University of Sydney Departments of **Melanoma and Surgical Oncology ‡Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital ∥Department of Medicine, Westmead Hospital ¶Westmead Institute for Cancer Research, Westmead Hospital ††The Kinghorn Cancer Centre, Garvan Institute of Medical Research ‡‡St Vincent's Clinical School, University of New South Wales, Sydney, Australia. · Pubmed 24335665
  • Department of Dermatology, Westmead Hospital, Sydney, New South Wales, Australia; Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Pubmed 24313958
  • Lisa Zimmer and Dirk Schadendorf, University Hospital, University Duisburg-Essen, Essen, Germany; Lauren E. Haydu, Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, John F. Thompson, and Georgina V. Long, Melanoma Institute Australia; Alexander M. Menzies, Richard A. Scolyer, Richard F. Kefford, and Georgina V. Long, Sydney Medical School, The University of Sydney; Richard A. Scolyer and John F. Thompson, Royal Prince Alfred Hospital; Lauren E. Haydu and John F. Thompson, The University of Sydney; John F. Thompson, Mater Hospital, Sydney; Richard F. Kefford and Georgina V. Long, Westmead Institute for Cancer Research, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 24297954
  • 1The Division of Dermatology, Department of Medicine, 2Division of Surgical Oncology, Department of Surgery, 3Division of Hematology and Oncology, Department of Medicine, 4Jonsson Comprehensive Cancer Center, 5Department of Molecular and Medical Pharmacology, 6David Geffen School of Medicine, University of California, Los Angeles, California; 7Melanoma Institute of Australia, 8Royal Prince Alfred Hospital, 9Westmead Millennium Institute, and 10Westmead Hospital, University of Sydney, New South Wales, Australia. · Pubmed 24265152
2013
  • Paolo A. Ascierto, Ester Simeone, Instituto Nazionale Tumori Fondazione "G. Pascale," Napoli, Italy; David Minor, California Pacific Center for Melanoma Research and Treatment, San Francisco; Antoni Ribas, Jonsson Comprehensive Cancer Center, University of California, Los Angeles; Omid Hamid, Experimental Therapeutics/Immunotherapy, The Angeles Clinic and Research Institute, Los Angeles, CA; Anne O'Hagan, Niki Arya, Mary Guckert, Anne-Marie Martin, Jolly Mazumdar, Vicki L. Goodman, GlaxoSmithKline Oncology, Collegeville; Ravi Amaravadi, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA; Kevin B. Kim, The University of Texas MD Anderson Cancer Center, Houston, TX; Celeste Lebbe, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Louis, Paris, Université Paris Diderot, Paris; Jean-Jacques Grob, Aix-Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Timone, Marseille, France; Dirk Schadendorf, University Hospital Essen, Essen; Tabea Wilhelm, Uwe Trefzer, Charité-Universitätsmedizin, Berlin, Germany; Richard F. Kefford, Georgina V. Long, Westmead Hospital and Melanoma Institute Australia, University of Sydney, Sydney, Australia. · Pubmed 23918947
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 23645591
  • Westmead Millennium Institute, The University of Sydney, Sydney, Australia. · Pubmed 22981500
  • Department of Dermatology(D5a), Westmead Hospital, Westmead, Sydney, NSW, 2145, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23870055
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 23582185
  • Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 23557327
  • Melanoma Institute Australia and Westmead Hospital, University of Sydney, 40 Rocklands Road, North Sydney, New South Wales, Australia. · Pubmed 23237741
  • University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 23190890
  • Melanoma Institute Australia and Westmead Hospital, 40 Rocklands Rd, North Sydney, NSW 2060, Australia. · Pubmed 23026937
  • The University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 22931913
2012
  • Melanoma Institute Australia, Westmead Institute for Cancer Research, and Westmead Hospital, The University of Sydney, Sydney, NSW, Australia. · Pubmed 23051966
  • Department of Dermatology, Westmead Hospital, Westmead, NSW 2145, Australia. · Pubmed 22804352
  • Surgery (Melanoma and Surgical Oncology), University of Sydney, Melanoma Institute Australia and Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, New South Wales. · Pubmed 22762064
  • Melanoma Institute Australia, Disciplines of Medicine, Surgery, Pathology, and Westmead Institute for Cancer Research, Westmead Millennium Institute, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 22535154
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute and Melanoma Institute Australia, Westmead Hospital, Westmead, New South Wales, Australia. · Pubmed 22437314
  • Cancer Epidemiology and Services Research, Sydney School of Public Health, The University of Sydney, Australia. · Pubmed 22095472
2011
  • Centre for Molecular, Environmental, Genetic and Analytic (MEGA) Epidemiology, Melbourne School of Population Health, University of Melbourne, VIC, Australia. · Pubmed 21472378
  • Melanoma Institute Australia, 40 Rocklands Rd, North Sydney, New South Wales, 2060, Australia. · Pubmed 21343559
  • Center for Molecular, Environmental, Genetic and Analytic Epidemiology, Melbourne School of Population Health, The University of Melbourne, Melbourne, Australia. · Pubmed 21325014
2010
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 20478260
  • Westmead Institute for Cancer Research and Melanoma Institute of Australia, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 20340136
2009
  • Westmead Institute for Cancer Research, Westmead Hospital, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · Pubmed 19212341
  • Westmead Institute for Cancer Research, University of Sydney, Westmead Millennium Institute and Westmead Hospital, Australia. · Pubmed 19149898
2008
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead NSW 2145, Australia. · Pubmed 18953432
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, NSW, Australia. · Pubmed 18843795
Macquarie University
2017
  • Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Gallipoli Medical Research Foundation, Greenslopes Private Hospital, Greenslopes, QLD, Australia; University of Queensland, Brisbane, QLD, Australia. · Olivia Newton-John Cancer Research Institute, Austin Health, School of Cancer Medicine, LaTrobe University, Heidelberg, VIC, Australia. · Regional Cancer Centre, Waikato Hospital, Hamilton, New Zealand. · Canterbury District Health Board, Christchurch Hospital, Christchurch, New Zealand. · Royal Prince Alfred Hospital, Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Chris O'Brien Lifehouse, Camperdown, NSW, Australia. · Tasman Oncology Research, Southport Gold Coast, QLD, Australia. · Department of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. · Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC, USA. · Department of Medicine, University of Washington, Seattle, WA, USA. · University of Texas MD Anderson Cancer Center, Houston, TX, USA. · Dana-Farber Cancer Institute, Boston, MA, USA. · Melanoma Institute Australia, University of Sydney, Mater Hospital, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Westmead Hospital, Melanoma Institute Australia, Macquarie University, Sydney, NSW, Australia. · Westmead Hospital, Westmead, NSW, Australia; Melanoma Institute Australia, University of Sydney, Sydney, NSW, Australia; Blacktown Hospital, Blacktown, NSW, Australia. · Merck & Co, Kenilworth, NJ, USA. · Pubmed 28729151
  • Department of Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne and University of Melbourne, Parkville, Australia. · AOU Senese Policlinico Santa Maria Alle Scotte, Siena, Italy. · Department of Medical Oncology, Hospital Clínic Barcelona, Spain. · Mount Vernon Hospital, Centre for Cancer Treatment, Northwood, UK. · The Netherlands Cancer Institute, Amsterdam, The Netherlands. · University Paris Descartes, Hospital Cochin, APHP, Paris, France. · Department of Dermatology, University Hospital Tuebingen, Tuebingen. · Department of Dermatology, University Hospital Schleswig-Holstein (UKSH), Campus Kiel, Kiel. · Department of Dermatology, Comprehensive Cancer Center, University Hospital Essen, Essen, Germany. · Angeles Clinic and Research Institute, Los Angeles, USA. · Fachklinik Hornheide, Munster, Germany. · Moffitt Cancer Center, Tampa, USA. · Chaim Sheba Medical Centre, Oncology Institute, Ramat-Gan, Israel. · Crown Princess Cancer Centre Westmead Hospital and Department of Clinical Medicine, Macquarie University, Sydney NSW, Australia. · Seattle Cancer Care Alliance, Seattle, USA. · F. Hoffmann-La Roche Ltd, Basel, Switzerland. · University of Colorado Cancer Center, Aurora. · City of Hope, Duarte, USA. · Pubmed 27993793
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. · Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · The University of Sydney at the Westmead Institute for Medical Research, Centre for Cancer Research, Westmead New South Wales, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales, Australia. · Royal North Shore Hospital, New South Wales, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Department of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. · Pubmed 28724663
  • Medical Oncology Unit, Austin Health, Melbourne, Victoria 3084, Australia. · Olivia Newton-John Cancer Research Institute, Melbourne, Victoria 3084, Australia. · La Trobe University School of Cancer Medicine, Melbourne, Victoria 3086, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales 2145, Australia. · The University of Sydney, Sydney, New South Wales 2006, Australia. · Medical Oncology Unit, Alfred Hospital, Melbourne, Victoria 3004, Australia. · Melanoma Institute Australia, Sydney, New South Wales 2060, Australia. · Peter MacCallum Cancer Centre, Melbourne, Victoria 3000, Australia. · Royal North Shore and Mater Hospitals, Sydney, New South Wales 2065, Australia. · Department of Clinical Medicine, Macquarie University, New South Wales 2109, Australia. · Pubmed 28524161
  • Melanoma Institute Australia, The University of Sydney, North Sydney, Sydney, New South Wales 2065, Australia. · QIMR Berghofer Medical Research Institute, Brisbane, Queensland 4006, Australia. · Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · Queensland Centre for Medical Genomics, Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland 4072, Australia. · Australian Institute of Tropical Health and Medicine, James Cook University, Cairns, Queensland 4878, Australia. · Los Alamos National Laboratory, Los Alamos, New Mexico 87545, USA. · Research Program on Biomedical Informatics, IMIM Hospital del Mar Medical Research Institute, Universitat Pompeu Fabra, 08003 Barcelona, Catalonia, Spain. · Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, 08028 Barcelona, Spain. · Centre for Cancer Research, Westmead Institute for Medical Research, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Medical Research Institute, The University of Sydney, Westmead, Sydney, New South Wales 2145, Australia. · Children's Hospital at Westmead, The University of Sydney, Westmead, New South Wales Sydney, 2145, Australia. · Bioplatforms Australia, North Ryde, Sydney, New South Wales 2109, Australia. · University of Melbourne Centre for Cancer Research, University of Melbourne, Parkville, Melbourne, Victoria 3052, Australia. · School of Mathematics and Statistics, The University of Sydney, Sydney, New South Wales 2006, Australia. · Olivia Newton-John Cancer Research Institute, La Trobe University, Austin Health, Heidelberg, Melbourne, Victoria 3084, Australia. · Macquarie University, North Ryde, Sydney, New South Wales 2109, Australia. · Centenary Institute, The University of Sydney, Sydney, New South Wales 2006, Australia. · Department of Medical Oncology, Royal North Shore Hospital, St Leonards, Sydney, New South Wales 2065, Australia. · Peter MacCallum Cancer Centre and University of Melbourne, Melbourne, Victoria 3000, Australia. · Institució Catalana de Recerca i Estudis Avançats (ICREA), 08010 Barcelona, Spain. · Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, Sydney, New South Wales 2050, Australia. · Pubmed 28467829
  • Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Department of Renal Medicine, Westmead Hospital, Westmead, NSW, Australia. · Department of Clinical Medicine, Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27863085
  • Department of Oncology-Pathology, Karolinska Institutet, Karolinska University Hospital. · Departments of Allogeneic Stem Cell Transplantation and Hematology, Karolinska University Hospital. · Division of Hematology, Department of Medicine Huddinge, Karolinska Institutet, Stockholm, Sweden. · Melanoma Unit, Royal Marsden NHS Foundation Trust, London. · Royal Marsden Hospital, London, UK. · Westmead Hospital, Melanoma Institute Australia and Macquarie University, Sydney, Australia. · Melanoma, Cancer Immunotherapy and Innovative Therapies Unit, Istituto Nazionale Tumori di Napoli Fondazione "G. Pascale", Naples, Italy. · Pubmed 28407116
2016
  • Division of Hematology and Oncology, University of California-Los Angeles, Los Angeles. · Department of Hematology/Oncology, The Angeles Clinic and Research Institute, Los Angeles, California. · Department of Hematology/Oncology, University of California-San Francisco, San Francisco. · Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. · Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia, Sydney, Australia7Department of Clinical Medicine, Macquarie University, Sydney, Australia. · Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. · Department of Clinical Research, South Texas Accelerated Research Therapeutics, San Antonio. · Department of Melanoma, The University of Texas MD Anderson Cancer Center, Houston. · Department of Cutaneous Oncology, H. Lee Moffitt Cancer Center, Tampa, Florida. · Division of Hematology and Oncology, Abramson Cancer Center at the University of Pennsylvania, Philadelphia. · Department of Medicine, University of Sydney, Sydney, Australia. · Division of Medical Oncology, Mayo Clinic, Rochester, Minnesota. · Department of Hematology/Oncology, Mayo Clinic, Jacksonville, Florida. · Department of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. · Department of Hematology/Oncology, Massachusetts General Hospital, Boston. · Department of Medical Oncology, Gustave-Roussy Cancer Campus and Paris Sud University, Villejuif Paris-Sud, France. · Department of Clinical Oncology, Merck & Co, Inc, Kenilworth, New Jersey. · BARDS, Merck & Co, Inc, Kenilworth, New Jersey. · Pubmed 27092830
  • Princess Alexandra Hospital, Greenslopes Private Hospital and University of Queensland, Brisbane, Queensland, Australia. · Melanoma Institute Australia, Royal North Shore and Mater Hospitals, The University of Sydney, Sydney, New South Wales, Australia. · Peter MacCallum Cancer Centre and Cabrini Health, Melbourne, Victoria, Australia. · Westmead Hospital, Sydney, New South Wales, Australia. · School of Medicine and Pharmacology, University of Western Australia and Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. · Queen Elizabeth Hospital, Adelaide, South Australia, Australia. · Westmead Hospital and Macquarie University, Sydney, New South Wales, Australia. · The Alfred Hospital, Melbourne, Victoria, Australia. · Olivia Newton John Cancer Wellness & Research Centre, Austin Health Melbourne, Victoria, Australia. · Pubmed 27905182
  • Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Royal North Shore Hospital, Sydney, NSW, Australia. · Mater Hospital, Sydney, NSW, Australia. · Department of Nuclear Medicine, Westmead Hospital, Sydney, NSW, Australia. · Faculty of Health and Medical Sciences, Macquarie University, Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27333363
  • Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Liz Plummer Cancer Centre, Cairns, Qld, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, NSW, Australia; Macquarie University, North Ryde, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Westmead Millennium Institute for Medical Research, Westmead, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia; School of Medicine, University of Western Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Camperdown, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; The University of Sydney, Sydney, NSW, Australia; Royal North Shore Hospital, Sydney, NSW, Australia. Electronic address: · Pubmed 27020391
2015
  • Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Merck Research Laboratories, Palo Alto, California. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Crown Princess Mary Cancer Centre, Westmead Hospital, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Kolling Institute of Medical Research, Royal North Shore Hospital, St. Leonards, New South Wales, Australia. · Melanoma Institute Australia, North Sydney, New South Wales, Australia. Sydney Medical School, the University of Sydney, Sydney, New South Wales, Australia. Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Pubmed 25609064
  • Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, New South Wales, Australia. Melanoma Institute Australia, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. · The Kinghorn Cancer Centre, Cancer Research Program, Garvan Institute of Medical Research, Sydney, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Department of Tissue Pathology and Diagnostic Oncology Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Melanoma Institute Australia, Sydney, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Westmead Institute for Cancer Research, University of Sydney at Westmead Millennium Institute, Westmead, New South Wales, Australia. Australian School of Advanced Medicine, Macquarie University, New South Wales, Australia. Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. · Pubmed 25370473
2017
  • From the Melanoma Institute Australia, University of Sydney, Royal North Shore and Mater Hospitals (G.V.L.), and Macquarie University, Melanoma Institute Australia, University of Sydney, and Westmead Hospital (R.K.), Sydney, Princess Alexandra Hospital, Gallipoli Medical Research Foundation, University of Queensland, Brisbane (V.A.), and Alfred Hospital, Melbourne, VIC (A. Haydon) - all in Australia; University Hospital Schleswig-Holstein, Kiel (A. Hauschild), and University Hospital Essen, Essen, and the German Cancer Consortium, Heidelberg (D.S.) - all in Germany; Fondazione Istituto Nazionale Tumori, Milan (M.S.), Papa Giovanni XXIII Cancer Center Hospital, Bergamo (M.M.), and the Melanoma Oncology Unit, Veneto Oncology Institute, Padua (V.C.-S.) - all in Italy; Rikshospitalet-Radiumhospitalet, Oslo (M.N.); Centre Hospitalier Universitaire de Bordeaux, Hôpital Saint-André, Bordeaux (C.D.), Institute Gustave Roussy, Paris (C.R.), Université de Lille, INSERM Unité 1189, Centre Hospitalier Régional Universitaire de Lille, Lille (L.M.), and the Medical Oncology Department, Centre Eugène Marquis, Rennes (T.L.) - all in France; Ella Institute for Melanoma, Sheba Medical Center, Tel Hashomer, Israel (J.S.); Royal Marsden NHS Foundation Trust, London (J. Larkin), and Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne (R.P.) - both in the United Kingdom; Novartis Pharmaceuticals, East Hanover, NJ (R.J., P.Z., B.M., J. Legos); University Hospital Zürich Skin Cancer Center, Zurich, Switzerland (R.D.); and the Melanoma Program, Hillman UPMC Cancer Center, University of Pittsburgh, Pittsburgh (J.M.K.). · Pubmed 28891408
  • Institut Universitaire du Cancer, Toulouse, France. · Gustave Roussy and Paris-Sud University, Villejuif, France. · Oslo University Hospital, Norway. · Peter MacCallum Cancer Centre and the University of Melbourne, Australia. · Winship Cancer Institute of Emory University, Atlanta, Georgia. · Lee Moffitt Cancer Center and Research Institute, Tampa, Florida. · National Cancer Center Hospital, Tokyo, Japan. · Massachusetts General Hospital, Boston, Massachusetts. · Department of Medical Oncology and Translational Genomics and Targeted Therapeutics in Solid Tumors, Hospital Clínic, Barcelona, Spain. · Crown Princess Mary Cancer Centre Westmead Hospital, Melanoma Institute Australia, University of Sydney, Sydney, New South Wales, Australia. · Macquarie University, Sydney, New South Wales, Australia. · Spanish National Cancer Research Centre (CNIO) and Centro Integral Oncologico Clara Campal, Madrid, Spain. · Institut Universitaire du Cancer, Toulouse, France. · Novartis Pharma AG, Basel, Switzerland. · Novartis Institutes for Biomedical Research, Cambridge, Massachusetts. · University Hospital Zurich, Zurich, Switzerland. · Pubmed 28611198
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
2016
  • Crown Princess Mary Cancer Centre, Westmead hospital, Westmead, NSW 2145, Australia. · Departments of Clinical Medicine and Biomedical Sciences, Macquarie University, NSW 2109, Australia. · Melanoma Institute Australia, North Sydney, NSW, Australia. · University of Sydney, Sydney, NSW, Australia. · Pubmed 27197541
  • Adil I. Daud, University of California, San Francisco, San Francisco; Antoni Ribas, University of California, Los Angeles; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles; Charlotte Roach and Grant Toland, Dako North America, Carpinteria, CA; Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Tara C. Gangadhar, Abramson Cancer Center at the University of Pennsylvania, Philadelphia; Hassane Zarour, University of Pittsburgh, Pittsburgh, PA; Roxana Dronca, Mayo Clinic, Rochester, MN; Jared K. Lunceford, Xiaoyun Nicole Li, Kenneth Emancipator, Marisa Dolled-Filhart, S. Peter Kang, and Scot Ebbinghaus, Merck & Co, Kenilworth, NJ; Caroline Robert, Gustave Roussy and Paris-Sud University, Villejuif, France; Anthony M. Joshua, Princess Margaret Cancer Centre, Toronto, ON, Canada; Richard Kefford, Crown Princess Mary Cancer Centre, Westmead Hospital and Melanoma Institute Australia; Richard Kefford, Macquarie University; and Richard Kefford and Peter Hersey, University of Sydney, Sydney, NSW, Australia. · Pubmed 27863197
  • F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · F. Stephen Hodi, Dana-Farber Cancer Institute, Boston, MA; Wen-Jen Hwu, The University of Texas MD Anderson Cancer Center, Houston; Amita Patnaik, South Texas Accelerated Research Therapeutics, San Antonio, TX; Richard Kefford, Westmead Hospital, Melanoma Institute Australia, and Macquarie University; Peter Hersey, University of Sydney, Sydney, Australia; Jeffrey S. Weber, H. Lee Moffitt Cancer Center, Tampa; Richard Joseph, Mayo Clinic, Jacksonville, FL; Adil Daud, University of California San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute; Antoni Ribas, University of California Los Angeles, Los Angeles, CA; Caroline Robert, Gustave-Roussy and Paris-Sud University, Villejuif-Paris-Sud, France; Tara C. Gangadhar, Abramson Cancer Center, Philadelphia, PA; Anthony M. Joshua, Princess Margaret Hospital, Toronto, Ontario, Canada; Roxana Dronca, Mayo Clinic, Rochester, MN; Darcy Hille, Dahai Xue, Xiaoyun Nicole Li, S. Peter Kang, Scot Ebbinghaus, and Andrea Perrone, Merck, Kenilworth, NJ; and Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center, New York, NY. · Pubmed 26951310
  • Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Georgina V. Long, Melanoma Institute Australia; The University of Sydney; Richard F. Kefford, Melanoma Institute Australia; The University of Sydney; Macquarie University, Sydney; Westmead Hospital, Westmead; Jonathan Cebon, Austin Health, Melbourne, Victoria, Australia; Jeffrey S. Weber and Ragini Kudchadkar, Moffitt Cancer Center, Tampa, FL; Jeffrey R. Infante and Howard A. Burris III, Sarah Cannon Research Institute/Tennessee Oncology; Kevin B. Kim, California Pacific Medical Center; Adil Daud, Alain Algazi, University of California, San Francisco, San Francisco; Omid Hamid, The Angeles Clinic and Research Institute, Los Angeles, CA; Rene Gonzalez, Karl Lewis, University of Colorado; Gerald S. Falchook, Sarah Cannon Research Institute at HealthONE, Denver, CO; Jeffrey A. Sosman, Igor Puzanov, Vanderbilt University Medical Center, Nashville, TN; Lynn Schuchter, University of Pennsylvania Abramson Cancer Center; Nageatte Ibrahim, Elizabeth Cunningham, Merck; Peng Sun, Amy S. Kline, Heather Del Buono, Diane Opatt McDowell, GlaxoSmithKline, Philadelphia, PA; Donald Lawrence and Kiran Patel, Incyte Corporation, Wilmington, DE; and Keith T. Flaherty, Massachusetts General Hospital Cancer Center, Boston, MA. · Pubmed 26811525
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
  • aCrown Princess Mary Cancer Centre bBlood and Marrow Transplant Service, Department of Haematology cDepartment of Clinical Immunology and Allergy, Westmead Hospital dFaculty of Medicine, The University of Sydney eMelanoma Institute Australia fFaculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26795275
2015
  • Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia. Electronic address: · Melanoma Institute Australia, Sydney, New South Wales, Australia; The Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia; The Mater Hospital, North Sydney, New South Wales, Australia. · Departments of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia; Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Centre for Cancer Research, Westmead Millennium Institute, Westmead, New South Wales, Australia; Melanoma Institute Australia, Sydney, New South Wales, Australia; Faculty of Medicine and Health Science, Macquarie University, New South Wales, Australia. · Pubmed 26358420
  • Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology, University Hospital, University Duisburg-Essen, Essen, Germany. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA; Department of Medical Oncology, City of Hope National Medical Center, Duarte, CA, USA. · Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia; Royal Prince Alfred Hospital, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Department of Dermatology and Allergy, Skin Cancer Center Hannover, Hannover Medical School, Hannover, Germany. · First Department of Medicine, University of Athens Medical School, Athens, Greece. · Melanoma Institute Australia, Sydney, NSW, Australia; Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia; Macquarie University, Sydney, NSW, Australia; Sydney Medical School, The University of Sydney, Sydney, NSW, Australia. · Translational Skin Cancer Research, German Cancer Consortium (DKTK), University Hospital Essen, Essen, Germany. · Department of Dermatology, Ludwig-Maximilians-University, Munich, Germany. · Department of Dermatology, University Hospital of Schleswig-Holstein, Kiel, Germany. · Department of Dermatology, University Medical Center, Mainz, Germany. · Department of Dermatology, University Hospital Zürich, Switzerland. · Centre for Cancer Research, The University of Sydney at The Westmead Millennium Institute, Westmead, NSW, Australia. · Department of Medicine, University of California Los Angeles (UCLA), Los Angeles, CA, USA. · Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA. · Pubmed 26608120
  • Melanoma Institute Australia, Sydney, Australia. · The University of Sydney, Sydney, Australia. · Royal North Shore Hospital, Sydney, Australia. · Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, Australia. · Royal Prince Alfred Hospital, Sydney, Australia. · Mater Hospital, Sydney, Australia. · Macquarie University, Sydney, Australia. · Pubmed 26218930
  • Department of Diabetes and Endocrinology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia. · Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia. · Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. · Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26010858
2014
  • 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Mater Hospital, North Sydney, New South Wales 2060, Australia. · 1] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia [3] Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Departments of Melanoma and Surgical Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Surgery, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Department of Surgical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Oncogenomics Laboratory, QIMR Berghofer Medical Research Institute, Herston, Brisbane, Queensland 4006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Departments of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Camperdown, New South Wales 2006, Australia [3] Discipline of Pathology, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia. · 1] Melanoma Institute Australia, Sydney, New South Wales 2060, Australia [2] Discipline of Medicine, Sydney Medical School, The University of Sydney, Sydney, New South Wales 2006, Australia [3] Precision Cancer Therapy Laboratory, Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales 2109, Australia [4] Westmead Institute for Cancer Research, The University of Sydney at Westmead Millennium Institute, Westmead Hospital, Westmead, New South Wales 2145, Australia. · Pubmed 25452114
Miscellaneous institutions in Sydney
2016
  • Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Royal North Shore Hospital, Sydney, NSW, Australia. · Mater Hospital, Sydney, NSW, Australia. · Department of Nuclear Medicine, Westmead Hospital, Sydney, NSW, Australia. · Faculty of Health and Medical Sciences, Macquarie University, Sydney, NSW, Australia. · Crown Princess Mary Cancer Centre, Sydney, NSW, Australia. · The University of Sydney, Sydney, NSW, Australia. · Melanoma Institute Australia, Sydney, NSW, Australia. · Pubmed 27333363
2017
  • Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead and Blacktown Hospitals, Sydney. · Translational Cancer Research Centre, The University of Sydney at The Westmead Institute, Sydney. · Melanoma Institute Australia, Sydney. · Sydney Medical School, The University of Sydney, Sydney. · Department of Medical Oncology, Northern Sydney Cancer Centre, Sydney. · Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia. · Pubmed 28327969
2016
  • Melanoma Institute Australia and The University of Sydney, Sydney, New South Wales, Australia. · Crown Princess Mary Cancer Centre Westmead, Sydney, New South Wales, Australia. · University of Sydney, Sydney, New South Wales, Australia. · Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione 'G. Pascale', Via Mariano Semmola, 80131 Napoli, Italy. · Regina Elena National Cancer Institute, Rome, Italy. · Royal North Shore Hospital, Sydney, New South Wales, Australia. · Faculty of Medicine and Health Sciences, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 27711085
2015
  • Department of Diabetes and Endocrinology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Department of Medical Oncology, Crown Princess Mary Cancer Centre, Westmead Hospital, Sydney, New South Wales, Australia. · Sydney Medical School, University of Sydney, Sydney, New South Wales, Australia. · Central Coast Cancer Centre, Gosford Hospital, Gosford, New South Wales, Australia. · Department of Endocrinology, Royal Prince Alfred Hospital, Sydney, New South Wales, Australia. · Department of Endocrinology, St Vincent's Hospital, Sydney, New South Wales, Australia. · Hormones and Cancer Group, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Melanoma Institute of Australia, Sydney, New South Wales, Australia. · Diabetes and Metabolism Division, Garvan Institute of Medical Research, Sydney, New South Wales, Australia. · Australian School of Advanced Medicine, Macquarie University, Sydney, New South Wales, Australia. · Pubmed 26010858
2011
  • Westmead Cancer Care Centre, Westmead, New South Wales, Australia. · Pubmed 21220617
71 Other Locations Show
Yearly article counts 01112152821181041142